• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Merge eFilm achieves record revenues

Article

Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an

Financial results for the third quarter, ended Sept. 30, at Merge eFilm showed a 44% increase in revenue over the year earlier period: $7.6 million compared with $5.3 million. Revenues were $20.2 million for the nine months ended Sept. 30, also an increase of 44% over the previous nine-month period. Net income for the quarter rose 55% to $1.6 million. Net income for the nine months increased 85% to $4.3 million. Results include approximately two and a half months of revenues from RIS Logic. The RIS Logic acquisition completed in late July strengthened Merge eFilm's product portfolio to include a full RIS/PACS solution. It also enhanced target market positioning and accelerated the effectiveness of operations, according to Richard A. Linden, Merge eFilm president and CEO.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.